Phathom Pharmaceuticals, Inc. SEC filings PHAT
Phathom Pharmaceuticals, Inc. has 495 filings in SEC EDGAR's recent list, going back to Jul 26, 2019. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 27, 2026 | — |
| 424B5 | Prospectus supplement | Jan 8, 2026 | — |
| 424B5 | Prospectus supplement | Jan 7, 2026 | — |
| S-3ASR | Automatic shelf registration | Jan 7, 2026 | — |
| S-8 | Employee stock plan registration | Apr 3, 2025 | — |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| 424B5 | Prospectus supplement | Aug 19, 2024 | — |
| FWP | Free writing prospectus | Aug 19, 2024 | — |
| S-3 | Shelf registration | Nov 9, 2023 | — |
| 424B5 | Prospectus supplement | May 24, 2023 | — |
| 424B5 | Prospectus supplement | May 23, 2023 | — |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| 424B5 | Prospectus supplement | Oct 26, 2021 | — |
| 424B5 | Prospectus supplement | Dec 17, 2020 | — |
| 424B5 | Prospectus supplement | Dec 15, 2020 | — |
| S-3 | Shelf registration | Nov 10, 2020 | — |
| S-8 | Employee stock plan registration | Oct 28, 2019 | — |
| 424B4 | Prospectus | Oct 28, 2019 | — |
| S-1MEF | Filing | Oct 24, 2019 | — |
| S-1/A | Amended registration statement | Oct 15, 2019 | — |
| S-1 | Registration statement | Sep 30, 2019 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PHAT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Florham Park, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1783183
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.